23.5 Structural Cardiac Procedures
Key Takeaways
Transfemoral access is the usual approach for TAVR when anatomy permits. CT helps the heart team plan annulus sizing and assess the access vessels.
Mitral edge-to-edge repair commonly uses femoral venous access, a transseptal route and real-time three-dimensional transesophageal echocardiography.
For left atrial appendage occlusion, use the selected device's release criteria. WATCHMAN FLX requires position, anchor, size and seal to be verified before release.
Imaging and sizing depend on the target and the closure device. Secundum atrial septal defect closure and patent foramen ovale closure have different anatomic assessments.
Pulmonary vein isolation is a core objective of atrial fibrillation ablation. Conventional pacing and defibrillator leads are commonly positioned with fluoroscopic guidance.
23.5 Structural Cardiac Procedures
Structural heart interventions use fluoroscopy plus procedure-specific imaging or hemodynamics. A heart team plans the intervention and assigns responsibility for image guidance, monitoring, recording and emergency support.
Transcatheter Aortic Valve Replacement
Transcatheter aortic valve replacement (TAVR) can treat appropriately selected patients with severe aortic stenosis, including some with confirmed low-flow, low-gradient disease. The heart team integrates symptoms, valve severity and patient factors. The delivery system carries a crimped bioprosthetic valve to the diseased valve. Balloon-expandable valves typically use rapid ventricular pacing during deployment to reduce movement. Self-expanding valves enlarge as the delivery system releases them. Position and deployment are assessed with the imaging and markers specified for the system.
Transfemoral access is the usual approach when the anatomy permits. In the Society of Thoracic Surgeons and American College of Cardiology registry, femoral access accounted for 95.3% of cases in 2019. That is a dated registry observation. Computed tomography (CT) helps size the annulus, characterize the root and assess whether the iliofemoral route can accommodate the device. Transcarotid, transaxillary and transcaval access are examples of alternatives considered when transfemoral anatomy is unsuitable.
After deployment the team assesses valve position and function, including paravalvular regurgitation, using aortography and echocardiography as indicated. Monitor the rhythm and vascular access site. A new conduction disturbance can prompt further evaluation or pacing. CT planning and procedural imaging inform decisions alongside the clinical findings.
Mitral Transcatheter Edge-to-Edge Repair
Mitral transcatheter edge-to-edge repair (TEER) uses a device to bring the leaflets together at the selected target to reduce mitral regurgitation. The usual route is femoral venous access with a transseptal puncture into the left atrium. Real-time three-dimensional transesophageal echocardiography (TEE) helps guide access, device orientation and leaflet capture. The team uses echo to assess residual regurgitation and the transmitral gradient before committing to release. The American Society of Echocardiography discusses three-dimensional intracardiac imaging as an option when TEE is unsuitable.
Occluders and Shunt Devices
Secundum atrial septal defect (ASD) device closure uses venous access and echocardiography to define the defect, surrounding rims and device relation to nearby structures. Balloon sizing depends on the specific device. The Amplatzer Septal Occluder instructions call for stop-flow balloon sizing. A patent foramen ovale (PFO) is a potential tunnel between septal layers, and the team uses its own morphology and device criteria to select and position a closure device. Echocardiography and fluoroscopy help confirm seating and the relation to adjacent structures before release.
A patent ductus arteriosus (PDA) connects the aorta and pulmonary artery. A transcatheter occluder can interrupt that connection. The delivery route and imaging depend on the device and patient size. The team evaluates residual flow and whether the device obstructs neighboring vessels.
Left atrial appendage occlusion (LAAO) is a stroke-prevention option for selected patients with nonvalvular atrial fibrillation. It commonly uses femoral venous and transseptal access. Preprocedure cardiac CT or TEE can characterize the appendage. Intraprocedural guidance can use TEE or intracardiac echocardiography (ICE) in the appropriate setting. TEE sizing uses several planes. For WATCHMAN FLX the operator assesses position, anchor, size and seal before device release. After release, final imaging and follow-up serve different purposes from the prerelease checks.
Electrophysiology and Implant Support
In an electrophysiology (EP) study, intracardiac electrograms show the sequence of electrical activation. An ablation catheter can target an accessory pathway or support isolation of the pulmonary veins in atrial fibrillation. Available approaches to pulmonary vein isolation include radiofrequency, cryoballoon and pulsed field ablation. Depending on the procedure, the operator combines electroanatomic mapping, echocardiography and fluoroscopy.
A conventional transvenous pacemaker or implantable cardioverter-defibrillator (ICD) uses leads advanced through a vein into the heart. Fluoroscopy helps show their route and position. Electrical testing checks whether the leads sense and stimulate as intended. Capture thresholds and impedance are examples of measurements recorded at implant. Section 23.6 compares the permanent systems and their electrical and imaging checks.
| Procedure | Example access | Key imaging or measurement |
|---|---|---|
| TAVR | Femoral artery when suitable | CT-based planning, fluoroscopy and assessment of valve function |
| Mitral TEER | Femoral vein with transseptal puncture | Real-time echocardiography for orientation, grasp, residual regurgitation and gradient |
| ASD or PFO closure | Femoral vein | Echocardiographic anatomy, device seating and neighboring structures |
| PDA closure | Device-specific route | Imaging of ductal anatomy, residual flow and nearby vessels |
| LAAO | Femoral vein with transseptal puncture | TEE or ICE during the procedure and device-specific prerelease checks |
| EP ablation | Venous access for many procedures | Intracardiac electrical recordings and mapping or imaging as appropriate |
| Conventional transvenous pacing or ICD | Cephalic, axillary, or subclavian vein | Fluoroscopic lead placement and electrical testing |
For current exam preparation, ARRT's separate Cardiac Interventional Radiography outline covers diagnostic and electrophysiology procedures and interventional procedures. Use the published outline for its own question distribution.
References
- ACC/AHA valve disease guideline and STS/ACC TAVR registry report
- ASE guidance for mitral TEER and FDA WATCHMAN FLX labeling
- Atrial fibrillation ablation consensus and conventional device implantation consensus
- SCAI alternative TAVR access consensus, SCAI/HRS appendage occlusion guideline, and Amplatzer septal occluder labeling
Which access and imaging pair is typical during mitral transcatheter edge-to-edge repair?
Transfemoral arterial access with aortography alone
Transapical surgical access without echocardiography
Femoral venous access with transseptal puncture and real-time three-dimensional TEE
Radial arterial access with intravascular ultrasound
The heart team is planning TAVR and reviewing CT of the iliofemoral arteries. Why does that assessment matter?
All TAVR valves use an apical route.
Subclavian access is always required before deployment.
Access vessel dimensions do not influence a transcatheter procedure.
The transfemoral route depends on adequate iliofemoral anatomy for the intended delivery system.
Sections you finish are checked off in the contents.